Arcus Biosciences (RCUS) Non Operating Income (2017 - 2026)
Arcus Biosciences' Non Operating Income came in at $5 million for Q2 2026, down 37.5% from $8 million a year earlier and down 16.7% from the prior quarter.
Arcus Biosciences (RCUS) Non Operating Income (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arcus Biosciences reported Non Operating Income of $26 million, down 36.6% year-over-year; for FY2025, it came in at $33 million, down 31.3% from FY2024.
- Non Operating Income carries a five-year compound annual growth rate of 101.2% (FY2020 to FY2025).
- Going back by year, Non Operating Income was $48 million in FY2024 (+23.1%), $39 million in FY2023 (+178.6%), $14 million in FY2022 and $1 million in FY2021 (unchanged).
- The five-year range for quarterly Non Operating Income is $161,000 (Q3 2021) to $13 million (Q3 2024).
- Year-over-year, Non Operating Income has declined for seven consecutive quarters, with an average decline of 23.7% over the last eight quarters.
- The fastest year-over-year change in Non Operating Income over five years came in Q2 2023 (growth of 350.0%), and the weakest in Q3 2025 (a decline of 46.2%).
- Business Quant data shows RCUS's Non Operating Income at $6 million (Q1 2026), $8 million (Q4 2025) and $7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Arcus Biosciences | 3.28 Bn | -53.05 Mn | - | 5.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 8.00 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | 13.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 11.00 Mn |
| Sep 30, 2023 | 11.00 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 8.00 Mn |
| Dec 31, 2022 | 7.00 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 191,000.00 |
| Dec 31, 2021 | 519,000.00 |
| Sep 30, 2021 | 161,000.00 |
Arcus Biosciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=RCUS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();